Pfizer stock rises Wednesday: What's going on?

Pfizer Inc PFE shares are trading higher Wednesday, moving in sympathy with mRNA cancer vaccine-related companies after Merck & Co Inc MRK and Moderna Inc MRNA announced that their combination therapy ...

BioNTech stock surges 22% on Moderna cancer vaccine win. Why the gains could fade.

BioNTech, a former pioneer of mRNA cancer vaccines, was part of a broad rally Wednesday. Leerink analysts don’t expect the momentum to last.
24/7 Wall St.

BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat

BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's ...

FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech

The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.
BioSpace

BioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancer

Shares of Germany-based BioNTech were down as much as 8% Friday after announcing a Phase 2 trial of autogene cevumeran would ...
FT Markets

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces ...

Today’s actions expand on Arbutus and Genevant’s ongoing enforcement proceeding in the U.S. District Court for the District of New Jersey, seeking fair compensation for Pfizer/BioNTech’s infringement ...

FDA approves updated COVID-19 vaccines from Pfizer & Moderna, companies say

The Food and Drug Administration approved updated COVID-19 vaccines from Pfizer-BioNTech and Moderna, the companies announced ...

Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update

Pfizer Inc , Biontech Se Sponsored Adr announced an update on their ongoing clinical study. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make s ...
Finanznachrichten

Arbutus Biopharma Corporation: Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna ...

Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle ("LNP") technology against Pfizer and ...